Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S. Viswanathan, Stuart L. Schreiber, Matthew J. Ryan et al.|Nature|2017Cited by 2k
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancerSrivatsan Raghavan, Alex K. Shalek, Peter Winter et al.|Cell|2021Cited by 586
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M. Sholl, Laura E. MacConaill, T. Khanh et al.|JCI Insight|2016Cited by 447
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N. Wasko, Miroslav Sekulic, Jingjing Jiang et al.|Nature|2024Cited by 175
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumorsAlbiruni RA Razak, Kyriakos P. Papadopoulos, James M. Cleary et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 117